Metastasis suppressory agents
US5985924A · kind A · utility
9Cited by
0References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 15, 1996 |
| Grant date | Nov 16, 1999 |
| Priority date | — |
| Expiry date | Nov 15, 2016 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides novel metastasis suppressory agents with a lowered degree of toxicity, comprising ursolic acid or its salt as an active ingredient, which can be administered to patients per os or through injection, thus enabling the patients to receive post-operative ambulatory treatment.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.